tDCS for Post-Stroke Cognitive Impairment
This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).
| Condition(s) | Stroke, Mild Cognitive Impairment |
|---|---|
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Summary | This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI). |
| Who can participate | Inclusion Criteria: 1\) ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA \<26); Exclusion Criteria: 1. clinically significant or unstable medical or psychiatric condition; 2. diagnosis of severe depression; 3. history of relevant neurological diagnosis (e.g., epilepsy); 4. previous neurosurgical procedure with craniectomy; 5. contraindications to tDCS (implanted brain medical devices); 6. severe visual impairment, hearing impairment, aphasia, neglect or dementia. |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Lead sponsor | University of Oklahoma |
| Locations | Oklahoma City, Oklahoma, United States |
| Start date | 2024-09-30 |
| NCT ID | NCT06516588 |
| Official listing | https://clinicaltrials.gov/study/NCT06516588 |